Impact of sarcopenia on chemotherapy‐triggered exacerbation of interstitial lung disease in patients with non‐small cell lung cancer
R Kikuchi, H Takoi, M Ishiwari, K Toriyama… - Thoracic …, 2022 - Wiley Online Library
Background While recent evidence has suggested that sarcopenia could predict
chemotoxicity, its association with chemotherapy‐triggered interstitial lung disease (ILD)
exacerbations has yet to be investigated. Thus, the present study sought to determine
whether sarcopenia could predict ILD exacerbations and overall survival (OS) in patients
with ILD‐complicated non‐small cell lung cancer (NSCLC). Methods From January 2010 to
July 2020, 74 patients with ILD‐complicated NSCLC who received chemotherapy were …
chemotoxicity, its association with chemotherapy‐triggered interstitial lung disease (ILD)
exacerbations has yet to be investigated. Thus, the present study sought to determine
whether sarcopenia could predict ILD exacerbations and overall survival (OS) in patients
with ILD‐complicated non‐small cell lung cancer (NSCLC). Methods From January 2010 to
July 2020, 74 patients with ILD‐complicated NSCLC who received chemotherapy were …
以上显示的是最相近的搜索结果。 查看全部搜索结果